← Leaderboards
Pal Pacher
Inotek Pharmaceuticals Corporation
$214,161
Attributed
$214,161
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$214,161 · 1
By mechanism
R43$214,161 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Garry John Southan$13,828,224
- Csaba Szabo$15,264,870
- Andrew L Salzman$19,918,828
- Prakash Jagtap$6,029,479
- Jon G Mabley$947,474
Others in their field
Top investigators on “Blood Pressure”
- David R. Weir · University Of Michigan At Ann Arbor$96,362,652
- Michael A Province · Washington University$60,417,406
- Leonardo Trasande · New York University School Of Medicine$55,277,738
- Rohit Varma · University Of Southern California$55,238,158
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$54,376,013
- Jiang He · Tulane University Of Louisiana$45,164,948
Research focus
Blood PressureCardiovascular AgentsDrug Design /Synthesis /ProductionDrug Screening /EvaluationFree Radical OxygenHeart RateHemodynamicsHemorrhagic ShockLaboratory RatPharmacokineticsResuscitationXanthine OxidaseXanthine Oxidase Inhibitor